Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2276-2280

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zacharowski, K.
Right arrow Articles by Thiemermann, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zacharowski, K.
Right arrow Articles by Thiemermann, C.
Related Collections
Right arrow Restenosis
Right arrow Animal models of human disease
Right arrow Ischemic biology - basic studies
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2276-2280.)
© 1999 American Heart Association, Inc.


Rapid Communication

Endotoxin Induces a Second Window of Protection in the Rat Heart as Determined by Using p-Nitro-Blue Tetrazolium Staining, Cardiac Troponin T Release, and Histology

Kai Zacharowski; Mike Otto; Gerd Hafner; Prabal K. Chatterjee; Christoph Thiemermann
Abstract—Pretreatment of rats with small doses of lipopolysaccharide (LPS), eg, for 24 hours, attenuates the cardiac dysfunction caused by subsequent period of myocardial ischemia. This phenomenon of enhanced tolerance to an ischemic insult has been termed "second window of protection." Although the cardioprotective effects of LPS were first reported in 1989, it is still unclear whether the observed attenuation by LPS of the ischemia-induced cardiac dysfunction is indeed secondary to the protection of cardiac myocytes against ischemic cell injury and death. This study was designed to investigate the effects of "preconditioning" with LPS on cell injury caused by regional myocardial ischemia and reperfusion in the anesthetized rat. Thirty-five Wistar rats were subjected to 25 minutes occlusion of the left anterior descending coronary artery followed by 2 hours of reperfusion. Hemodynamic parameters were continuously recorded, and at the end of the experiments, infarct size (using p-nitro-blue tetrazolium staining), cardiac troponin T release, and histological markers of cell injury and death were determined. In rats pretreated with a bolus of saline (vehicle for LPS) 2 or 24 hours before left anterior descending coronary artery occlusion and reperfusion, the infarct size was 59±4% (2 hours saline-control, n=6) and 61±3% (24 hours saline-control, n=6), respectively. Pretreatment of animals with a bolus of LPS (1 mg/kg IP) 24 hours before the onset of myocardial ischemia and reperfusion reduced both infarct size (to 18±7%; P<0.05, n=6) as well as histological signs of cell injury. Pretreatment (24 hours, as above) of rats with LPS also reduced the release of cardiac troponin T from 58±13 ng/mL (saline-control) to 16±9 ng/mL. In contrast, pretreatment of rats with LPS (2 hours, as above) did not affect infarct size (56±8%, n=6), cardiac troponin T release, or the histological parameters of cell injury. These data provide the first conclusive evidence that pretreatment of rats with a bolus of LPS 24 hours before intervention reduces the cell injury and death caused by a subsequent period of myocardial ischemia and reperfusion.


Key Words: LPS • myocardial infarct size • myocardial ischemia • reperfusion • delayed preconditioning




This article has been cited by other articles:


Home page
FASEB J.Home page
E. I. Chang, R. G. Bonillas, S. El-ftesi, E. I. Chang, D. J. Ceradini, I. N. Vial, D. A. Chan, J. Michaels V, and G. C. Gurtner
Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds
FASEB J, March 1, 2009; 23(3): 906 - 915.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Chao
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H1 - H12.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Feng, H. Zhao, X. Xu, E. S. Buys, M. J. Raher, J. C. Bopassa, H. Thibault, M. Scherrer-Crosbie, U. Schmidt, and W. Chao
Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1311 - H1318.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
H. Stapel, S.-C. Kim, S. Osterkamp, P. Knuefermann, A. Hoeft, R. Meyer, C. Grohe, and G. Baumgarten
Toll-like receptor 4 modulates myocardial ischaemia-reperfusion injury: Role of matrix metalloproteinases
Eur J Heart Fail, November 1, 2006; 8(7): 665 - 672.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. R. Bornstein, P. Zacharowski, R. R. Schumann, A. Barthel, N. Tran, C. Papewalis, V. Rettori, S. M. McCann, K. Schulze-Osthoff, W. A. Scherbaum, et al.
Impaired adrenal stress response in Toll-like receptor 2-deficient mice
PNAS, November 23, 2004; 101(47): 16695 - 16700.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. T. Beranek
Comments to the Editor Concerning the Paper Entitled "Effects of Endotoxin on Neutrophil-Mediated Ischemia/Reperfusion Injury in the Rat Heart In Vivo" by Lipton et al.
Experimental Biology and Medicine, April 1, 2002; 227(4): 223 - 224.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Zacharowski, S. Frank, M. Otto, P. K. Chatterjee, S. Cuzzocrea, G. Hafner, J. Pfeilschifter, and C. Thiemermann
Lipoteichoic Acid Induces Delayed Protection in the Rat Heart : A Comparison With Endotoxin
Arterioscler Thromb Vasc Biol, June 1, 2000; 20(6): 1521 - 1528.
[Abstract] [Full Text] [PDF]